IG Hanf represents the Swiss cannabis industry towards media, politics and the public. It is present at trade fairs and invites to events. Members have access to information and networking, IG Hemp offers a platform for discussions and collects data on the cannabis market.
Cannabis edibles – health risk or “harm reduction”?
Despite being perceived as a low-risk form of consumption, edibles are banned under German cannabis…
Cannabis regulation in Germany – opportunities and side effects for Switzerland
Interview with Peter Steger, President of IG MedCan and board member of the Swiss Society…
Initial results of the Swiss cannabis pilot trials draw attention
The first results from the cannabis pilot trials in Zurich and Basel were recently published….
Comparison of the Swiss / German regulatory models
due to the vote in the German Bundestag on 23 February 2024 After the German…
Cannabisregulierung mit staatlicher Abgabe? – Stellungnahme der IG Hanf
Positionspapier nicht psychotrope Cannabinoid-haltige Produkte
Jahresrückblick 2023
Der Vorstand und das Sekretariat der IG Hanf bedanken sich herzlich für die Unterstützung und…
Statement of IG Hanf Schweiz to the Federal Office of Public Health on the regulation of hemp products under tobacco law
Hemp is not tobacco IG Hemp Switzerland was asked for a statement in the context…
Statement in the context of the consultation on the Ordinance on Tobacco Products and Electronic Cigarettes (TabPV)
Dear President of the Swiss Confederation We thank you for the opportunity to comment on…
Health risks from designer drugs: Banning further psychoactive substances
After several substances with a suspected psychoactive effect had already been listed in the Schedule…
You want cannabis legal? – go vote!
Landmark elections are taking place this fall. The National Council and Council of States will…
Swiss cannabis regulation takes next hurdle
On September 28, 2023, the National Council approved the extension of the parliamentary initiative of…
